CliffBio
small molecule

NEXTERONE

AMIODARONE HYDROCHLORIDE

Loss of exclusivityMarch 2029latest FDA-listed patent expiry
CompanyBaxter Healthcare Corp →View the full company profile on CliffBio

Drug detail

Brand nameNEXTERONE
Active ingredientAMIODARONE HYDROCHLORIDE
Strength50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalDecember 2008
Marketing statusDISCN

Listed patents

PatentExpiresType
7635773March 2029product

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

NEXTERONE patent cliff — loss of exclusivity March 2029 | CliffBio